Trial Profile
A Study to Evaluate Pharmacokinetics of Mirabegron After Single and Multiple Oral Administration to Healthy Non-elderly Male and Female Chinese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jan 2013
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder; Urination disorders
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 11 Jan 2013 New trial record